Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Oro-facial granulomatosis is neither Crohn's nor a new IBD

The most recent issue of Inflammatory Bowel Diseases reports that oro-facial granulomatosis with associated intestinal inflammation may represent a separate entity of inflammation in the gastrointestinal tract in response to an unknown antigen.

News image

fiogf49gjkf04

Oro-facial granulomatosis is a rare chronic inflammatory disorder presenting characteristically with lip swelling.

The inflammatory disorder also affects the gingivae, buccal mucosa, floor of mouth, and a number of other sites in the oral cavity.

Histologically, oro-facial granulomatosis resembles Crohn's disease, and a number of patients with Crohn's have oral involvement identical to oro-facial granulomatosis.

However, the exact relationship between oro-facial granulomatosis and Crohn's remains unknown, which Dr Jeremy Sanderson and colleagues explored.

The research team identified 35 patients with oro-facial granulomatosis and no gut symptoms from a combined oral medicine/gastroenterology clinic.

All patients underwent a standardized assessment of the oral cavity and oral mucosal biopsy.

The standardized assessment was necessary to characterize the number of sites affected and the type of inflammation involved.

The researchers also recorded hematological and biochemical parameters of the patients.

Granulomas were present in 64% and colonic abnormalities in 54%
Inflammatory Bowel Diseases

The team reported that all 35 patients underwent ileocolonoscopy and biopsy to assess the presence of coexistent intestinal inflammation.

The researchers detected ileal or colonic abnormalities in 54% of cases.

From gut biopsies, the team noted that granulomas were present in 64% of cases.

The researchers found that an intestinal abnormality was significantly more likely if the age of oro-facial granulomatosis onset was less than 30 years.

Those with more severe oral inflammation were also more likely to have intestinal inflammation.

The research team observed a correlation between the histologic severity of oral inflammation and the histologic severity of gut inflammation.

No relationship was found between any blood parameter and intestinal involvement.

Dr Sanderson's team concluded, “Endoscopic and histologic intestinal abnormalities are common in patients with oro-facial granulomatosis with no gastrointestinal symptoms.”

“Younger patients with oro-facial granulomatosis are more likely to have concomitant intestinal involvement.”

“In these patients, granulomas are more frequent in endoscopic biopsies than reported in patients with documented Crohn's disease.”

“Oro-facial granulomatosis with associated intestinal inflammation may represent a separate entity in which granulomatous inflammation occurs throughout the gastrointestinal tract in response to an unknown antigen or antigens.”

Inflamm Bowel Dis 2005: 11(9): 840-6
24 August 2005

Go to top of page Email this page Email this page to a colleague

 25 May 2018 
Colorectal cancer–specific mortality
 25 May 2018 
Technology to increase colorectal cancer screening
 25 May 2018 
Post‐operative complications in elderly IBD
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 24 May 2018 
Precision medicine for tumors
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 23 May 2018 
High body mass index is and ulcerative colitis
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Depressive symptoms in IBD youth
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Fecal incontinence and quality of life in IBD
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us